Israeli R&D Team Claim To Be Near COVID-19 Vaccine
MIGAL Researchers Had Already Developed An Avian Coronavirus Vaccine
An Israeli research team has discovered a potential COVID-19 vaccine candidate as a by-product of an avian vaccine they were developing and one of the team’s leaders told Scrip they hope to start producing and testing it by May.
You may also be interested in...
Shrinking cash and COVID-19 uncertainty have prompted Nordic Nanovector to slash costs and focus purely on its lead asset’s pivotal trial in third-line follicular lymphoma.
Sanofi to sell most of its Regeneron stake, with much of it being re-purchased by Regeneron, but both stressed the move would not hurt their long established and very profitable drug-development collaboration.
Sweden-based Kancera hopes to advance its investigative anti-inflammation drug in a Phase II trial to treat severe COVID-19 patients and then build its applications from there.